Wacker Biotech US Inc. is the new name of Genopis Inc., the plasmid DNA manufacturer based in San Diego, CA, that Wacker acquired in February. The acquisition concerns a plasmid DNA (pDNA) CDMO site and its associated business.
The Munich, Gemany-based chemical company Wacker is acquiring 100 percent of the shares in pharmaceutical contract manufacturer Genopis from South Korea-based firms Helixmith and Medivate Partners.
By entering this strategic partnership agreement, GenScript and Genopis establish a revenue-sharing agreement for the promotion, selling, and production of GMP plasmids globally.